Skip to main content

News Archive

News Archive - Scott LaFee

Cheryl Anderson Named Founding Dean of School of Public Health at UC San Diego

June 1, 2020

Dr. Cheryl Anderson, professor and interim chair of the Department of Family Medicine and Public Health in the School of Medicine at the University of California San Diego, has been named founding dean of The Herbert Wertheim School of Public Health and Human Longevity Science.

RNA Molecules in Maternal Blood May Predict Pregnancies at Risk for Preeclampsia

May 19, 2020

UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

May 15, 2020

The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.

Introducing the UC San Diego Return to Learn Program

May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

May 4, 2020

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

April 29, 2020

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Loss of Smell Associated with Milder Clinical Course in COVID-19

April 27, 2020

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

For ME/CFS Patients, Viral Immunities Come at a Devastating, Lifelong Cost

April 27, 2020

Researchers at UC San Diego School of Medicine and three German universities describe an underlying biological basis for myalgic encephalomyelitis/chronic fatigue syndrome, illustrating how efforts by the body to boost immune system protections can come at physiological cost elsewhere.

UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure

April 17, 2020

Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
Category navigation with Social links